The eye research is more interesting than most people expect, and it splits into two distinct threads. It is also the area where the gap between clinical research and consumer devices is widest, so the safety point comes first.
Never look into a red light therapy panel. Everything described below uses purpose-built clinical devices under supervision. Body panels are built to deliver energy across large areas of skin and are far more powerful than the ocular devices used in this research. Eye protection is worn during our sessions.
Thread one: treating retinal disease
The first is retinal photobiomodulation, where near-infrared light is applied to treat retinal disease.
Randomised trials in dry age-related macular degeneration have reported improvements in visual acuity and drusen volume, and this remains an active clinical research area.
Two things make this notable. Dry AMD is the leading cause of sight loss in older adults in developed countries, and unlike wet AMD it has had very little in the way of treatment. Any credible option matters.
And drusen volume is a structural measurement. Drusen are deposits under the retina that accumulate in AMD, and they are visible on imaging. A change in drusen volume is a change in the eye itself, not a change in how well someone read a chart on the day.
This is delivered through specific clinical devices in supervised protocols, not by sitting in front of a panel.
Thread two: myopia control in children
The second is red light for myopia control in children, where trials in East Asia have reported slowed axial elongation.
Myopia is rising sharply, particularly in East Asia, and it is not merely an inconvenience. High myopia increases lifetime risk of retinal detachment, glaucoma and myopic maculopathy. Slowing the elongation of the eyeball during childhood reduces those risks later, which is why this is taken seriously.
But this comes with a caveat we are not going to soften. Safety questions about retinal exposure are being actively debated and some researchers have raised concerns.
Delivering light directly into a developing child's eye, repeatedly, over years, is exactly the situation where long-term safety data matters most and exists least. Some published cases and commentaries have raised concerns about retinal changes. The debate is live and unresolved.
If you have a myopic child, this is a conversation for a paediatric ophthalmologist, who can also discuss the better-established options for myopia control.
What this means for anyone reading at home
Both use specific clinical devices and supervised protocols. Neither is something a full body system delivers, and eye protection is worn during our sessions.
The devices used in this research are engineered for ocular delivery: specific wavelength, tightly controlled low power, defined exposure time, professional supervision. A body panel shares none of those characteristics except roughly the wavelength.
Bright light sources can cause photochemical retinal injury, and the retina does not repair. This is the one place on this website where getting it wrong is not recoverable.
What we recommend
- Wear eye protection during any full body session, or keep your eyes closed and turned away
- Never look directly at the emitters, even briefly, even to check they are on
- Do not point a panel at a child's face
- Have your eyes checked regularly. Most serious eye disease is silent early on, which is exactly why routine examination matters
When to see an eye specialist
Any change in vision needs an optometrist or ophthalmologist.
Seek urgent attention for sudden vision loss, a sudden increase in floaters or flashes of light, a curtain or shadow across your vision, sudden eye pain with redness and blurred vision, or double vision that comes on suddenly. Retinal detachment and acute glaucoma are emergencies where hours matter.
Arrange a routine check for gradual blurring, difficulty reading, distorted straight lines, which is a classic early AMD sign, or worsening night vision.
Common questions
Does red light therapy improve vision? Randomised trials of retinal photobiomodulation in dry age-related macular degeneration report improvements in visual acuity and drusen volume, using clinical devices under supervision.
Can I use my panel for my eyes? No. Never look into a red light therapy panel. The research uses purpose-built ocular devices at far lower power.
Does red light slow myopia in children? Trials in East Asia report slowed axial elongation, but safety questions about retinal exposure are actively debated. Speak to a paediatric ophthalmologist.
Do I need eye protection during a session? Yes. Eye protection is worn during our sessions.
Is this available as a treatment? Retinal photobiomodulation is delivered clinically, not at home. Ask an ophthalmologist about current options and trials.
Where this leaves things
Genuinely promising clinical research, in supervised settings, using devices built for the purpose. Nothing you should attempt with a consumer panel, and one of the few areas of this subject where the downside of getting it wrong is permanent.
For the well-supported uses of light therapy, see our pages on skin, recovery and pain, or browse our Future Form systems.
